Hui Jin
Direktor/Vorstandsmitglied bei Zhejiang Hongyuan Pharmaceutical Co., Ltd.
Profil
Hui Jin currently works at Zhejiang Hongyuan Pharmaceutical Co., Ltd., as Director & Manager.
Aktive Positionen von Hui Jin
| Unternehmen | Position | Beginn |
|---|---|---|
Zhejiang Hongyuan Pharmaceutical Co., Ltd.
 Zhejiang Hongyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Hongyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredient (API) of cardio-cerebral vascular drugs, intermediates, and other chemicals. Its products include intermediates of Atorvastatin Calcium, Rosuvastatin Calcium, Pregabalin, Empagliflozin, Sotagliflozin, Teneligliptin, Betrixaban, Edoxaban, Sacubitril, Baricitinib, Lifitegrast, Roxadustat, Palbociclib, Ribociclib, Abemaciclib, Rucaparib, and Duloxetine. The company was founded on June 16, 2005 and is headquartered in Hangzhou, China. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Zhejiang Hongyuan Pharmaceutical Co., Ltd.
Zhejiang Hongyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Hongyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredient (API) of cardio-cerebral vascular drugs, intermediates, and other chemicals. Its products include intermediates of Atorvastatin Calcium, Rosuvastatin Calcium, Pregabalin, Empagliflozin, Sotagliflozin, Teneligliptin, Betrixaban, Edoxaban, Sacubitril, Baricitinib, Lifitegrast, Roxadustat, Palbociclib, Ribociclib, Abemaciclib, Rucaparib, and Duloxetine. The company was founded on June 16, 2005 and is headquartered in Hangzhou, China. | Health Technology |
